scholarly journals Smoking Cessation by Electronic Cigarettes and Applied Artificial Intelligence

2020 ◽  
Vol 9 (1) ◽  
Author(s):  
Henglong Ma ◽  
Charlie Huang ◽  
Crystal Dunlevy
Keyword(s):  
Artificial Intelligence ◽  
Health Care ◽  
Smoking Cessation ◽  
Electronic Cigarettes ◽  
Quit Smoking ◽  
Applied Artificial Intelligence

Numerous fields and administrations are embracing smart robotics. Despite the vast advancements in robotics for health care, there is limited practice and examination on utilizing electronic cigarettes (e-cigarettes, e-cigs, ENDS) and applied artificial intelligence (AI) to aid tobacco consumers to quit smoking. E-cigs and AI are certainly significant tools that have the potential in helping Americans reduce smoking. It can be valuable for society to determine if e-smoking (smoking e-cigs) is much safer and cleaner than traditional smoking.

The Pharmacist “Toolbox” for Smoking Cessation

2012 ◽  
Vol 25 (6) ◽  
pp. 591-599 ◽  
Author(s):  
William P. Wynn ◽  
Ron T. Stroman ◽  
Michaela M. Almgren ◽  
Kelly J. Clark
Keyword(s):  
Health Care ◽  
Smoking Cessation ◽  
Health Care Professionals ◽  
Electronic Cigarettes ◽  
The United States ◽  
Review Article ◽  
Prescription Medications ◽  
Over The Counter ◽  
Quit Smoking ◽  
Traditional Therapies

Annually there are 500 000 preventable deaths in the United States caused by smoking; as health care professionals, pharmacists have a unique opportunity to advise, assess, and assist patients to quit smoking. This review article provides pharmacists with a “toolbox” containing an overview of pharmacologic and nonpharmacologic methods for smoking cessation. Currently approved over-the-counter (OTC) and prescription medications (nicotine replacement therapy, varenicline, and bupropion) are summarized, and nonpharmacologic therapies discussed include cognitive therapy and hypnosis. In addition to traditional therapies some potential approaches to smoking cessation are addressed, including nicotine immunizations and electronic cigarettes.

scholarly journals Electronic cigarettes

2017 ◽  
Author(s):  
Spencer Kaspick ◽  
BCIT School of Health Sciences, Environmental Health ◽  
Helen Heacock
Keyword(s):  
Smoking Cessation ◽  
Electronic Cigarettes ◽  
Smoking Status ◽  
Electronic Cigarette ◽  
Cigarette Use ◽  
Chi Square ◽  
Post Secondary ◽  
Quit Smoking ◽  
Quitting Smoking ◽  
Chi Squared

  Background: Electronic cigarettes are a widely-used, yet still emerging technology. As such, there is relatively little data regarding the reasons why people take up their use. Many claim to use them as a smoking-cessation method. Concern exists that experimentation in non-smokers may lead to nicotine addiction and subsequent smoking. The purpose of this study was to determine the primary reasons for the commencement of electronic cigarette use, and to suggest way in which these findings could affect current policies and regulations pertaining to electronic cigarettes. Methods: A survey examining electronic cigarette use was prepared. The survey contained questions respecting primary motivation for use, frequency of use, present and former smoking status as well as agreement with common perception about electronic cigarettes. Basic demographic information was also collected. The survey was posted to “www.reddit.com” and was accessible to users who used electronic cigarettes themselves via the “/r/electronic_cigarettes” sub-Reddit for a period of five days. Once responses were collected, Chi-square tests of independence were run to determine if any associations existed. Responses were also compared to previous studies of a similar nature to see if any similarities existed. Results: In total, 155 responses were received. The majority of the respondents were males (89.7%) between the ages of 19 and 28 (47.7%). 30.32% listed their occupation as “student”, and almost three-quarters of the respondents had some post-secondary experience. 78.1% of respondents were former smokers, and 61.3% identified their primary reason for electronic cigarette use as “to quit smoking.” Chi-squared tests for association between responses yielded statistically-significant associations between being a previous smoker and believing that electronic-cigarettes are healthier than conventional cigarettes, and between gender (specifically being male) and reasons for electronic cigarette use (specifically “to quit smoking”). However, the latter result was possibly skewed by a higher response rate from males as opposed to females. Conclusion: The high proportion of previous smokers among electronic cigarette users suggested that quitting smoking was the most common reason individuals take up electronic cigarette usage. It is therefore suggested that studies be done to determine if their use is less harmful than that of conventional cigarettes, and that existing legislation regarding their use in public be modified in light of this evidence. It is also suggested that they be given consideration as a legitimate means of smoking cessation.  

scholarly journals Smoking cessation interventions in nurses and other health care workers

2011 ◽  
Vol 2 (1) ◽  
pp. 29-39 ◽  
Author(s):  
Giuseppe La Torre ◽  
Rosella Saulle ◽  
Francesco Di Nardo ◽  
Tiziana Germani
Keyword(s):  
Health Care ◽  
Smoking Cessation ◽  
Health Care Workers ◽  
Tobacco Smoking ◽  
Smoking Prevalence ◽  
Short Term ◽  
Recurrence Rates ◽  
Quit Smoking ◽  
Transdermal Nicotine ◽  
Care Workers

Introduction: Tobacco smoking can be considered an old and a new challenge for public health. The aim of this review was to analyse different smoking cessation interventions aiming at health care workers.Methods: A literature search of electronic journal databases for studies on smoking cessation interventions among health care workers was performed according to PRISMA criteria, using the MEDLINE and Scopus databases.Results: Smoking restriction policies shouldn’t be considered as actual interventions, being ineffective, unpopular and reducing willingness to quit smoking in many subjects. Even though pharmacological therapies based on bupropion SR and transdermal nicotine patches grant significant results on the short-term (weeks and months), smoking recurrence rates are high and individualised interventions should be preferred or integrated since they seem to grant better results on the longterm (years).Conclusions: There is evidence that smoking cessation interventions among health care workers can be effective. This is of particular interest both for reducing tobacco smoking prevalence among this type of workers and for helping them to be useful model for the general population.

Smoking and schizophrenia

2017 ◽  
Author(s):  
David J. Castle ◽  
Peter F. Buckley ◽  
Fiona P. Gaughran
Keyword(s):  
Smoking Cessation ◽  
Side Effects ◽  
Cigarette Smoking ◽  
Replacement Therapy ◽  
Nicotine Replacement Therapy ◽  
Cognitive Enhancement ◽  
Electronic Cigarettes ◽  
Social Affiliation ◽  
Quit Smoking ◽  
Neuropsychiatric Side Effects

Rates of cigarette smoking are extremely high among people with schizophrenia. Reasons include social affiliation factors, negative symptom amelioration, and cognitive enhancement. It is crucial that people with schizophrenia are provided with information about the risks associated with smoking and given the opportunity to engage in smoking cessation programmes. Medications such as nicotine replacement therapy, bupropion, and varenicline can be used effectively and safely, but extra vigilance for neuropsychiatric side effects is required. There is potentially a role for electronic cigarettes in helping people with schizophrenia quit smoking, but more research is required in this regard.

Providing Medication Therapy Management for Smoking Cessation Patients

2014 ◽  
Vol 28 (1) ◽  
pp. 21-25 ◽  
Author(s):  
Tiffany D. Smalls ◽  
Amelia D. Broughton ◽  
Ericka V. Hylick ◽  
Todd J. Woodard
Keyword(s):  
Health Care ◽  
Smoking Cessation ◽  
Health Care Providers ◽  
Critical Role ◽  
The United States ◽  
Medication Therapy Management ◽  
Care Providers ◽  
Therapy Management ◽  
Medication Therapy ◽  
Quit Smoking

Nearly 50 years ago, the Surgeon General of the US Public Health Service released the first report of the Surgeon General’s Advisory Committee on Smoking and Health. The report concluded that cigarette smoking caused lung and laryngeal cancer as well as bronchitis. Today, smoking is one of the leading preventable causes of deaths in the United States. Research has shown that it potentially causes more deaths than human immunodeficiency virus, illegal drug use, alcohol use, motor vehicle injuries, and firearm-related incidents. Health care providers play a critical role in guiding and directing patients to quit smoking by introducing them to smoking-cessation options. This is due to the fact that if these patients quit, they can reduce their cardiovascular risk. Pharmacists, being one of the easily accessible health care providers, have an advantage over other clinicians when it comes to influencing patients to quit smoking and to modify their lifestyles. Pharmacists through medication therapy management directly interact with these patients to manage medications as well as behavioral factors.

P4394Two-year therapeutic effectiveness of pharmacotherapy versus electronic cigarettes for smoking cessation: A single-center experience

2019 ◽  
Vol 40 (Supplement_1) ◽  
Author(s):  
N Ioakeimidis ◽  
C Vlachopoulos ◽  
C Georgakopoulos ◽  
I Dima ◽  
V Gardikioti ◽  
...  
Keyword(s):  
Smoking Cessation ◽  
Treatment Period ◽  
Electronic Cigarettes ◽  
Smoking Abstinence ◽  
Single Center Experience ◽  
Quit Smoking ◽  
End Of Treatment ◽  
Continuous Abstinence ◽  
Traditional Risk Factors ◽  
Artery Disease

Abstract Purpose Aim of this study is to compare the long-term (2-year) effectiveness of e-cigarettes (EC) vs pharmacotherapy for smoking cessation. Methods We analyzed data from 173 smokers visiting our unit from January 2012 to December 2016 followed for two years. Of them, 128 were treated with varenicline for 3 months and 45 used EC for 3 months to quit smoking. Results There were not significant differences in severity of nicotine dependence and cigarette consumption (pack-years) between the two groups. Compared to smokers under varenicline therapy, EC users were younger (38±7 vs 49±12 years, P<0.01). The two groups had no gender difference and similar prevalence of traditional risk factors and coronary artery disease. Figure shows the smoking abstinence rates at the end of treatment period (3 months) and the continuous abstinence rates at 2 years. At the end of treatment period, 79 (62%) of subjects under therapy with varenicline were abstinent from smoking while 31 (69%) of individuals using EC did not smoke combustile cigarettes 3 months after the initiation of vaping. The continuous abstinence rates at 2 years was significantly higher among individuals treated with varenicline compared to EC (41% vs 24%, P<0.05). Interestingly, at 2 years, 12 EC users (27%) continued vaping alone and 21 (47%) were dual (EC and tobacco cigarette) users. EC vs varenicline and smoking abstinence Conclusions Our preliminary data indicate that smokers who received varenicline had significantly higher continuous abstinence rates compared to individuals who used EC at a 2-year follow-up. Furthermore, almost half of the later group maintained dual use.

scholarly journals Chronic Idiopathic Neutrophilia in A Smoker, Relieved after Smoking Cessation with the Use of Electronic Cigarette: A Case Report

2013 ◽  
Vol 6 ◽  
pp. CCRep.S11175 ◽  
Author(s):  
Konstantinos E. Farsalinos ◽  
Giorgio Romagna
Keyword(s):  
Smoking Cessation ◽  
Blood Cell ◽  
White Blood Cell ◽  
Electronic Cigarettes ◽  
Underlying Disease ◽  
Electronic Cigarette ◽  
C Reactive Protein ◽  
Protein Levels ◽  
Reactive Protein ◽  
Quit Smoking

Introduction Smoking is a major risk factor for a variety of diseases. Electronic cigarettes are battery-operated devices that deliver nicotine to the lungs by evaporation of a liquid. Chronic idiopathic neutrophilia is a condition characterized by elevated white blood cell and neutrophil counts without any underlying disease; smoking has been implicated as a potential cause. Case Presentation A male Caucasian patient, born in 1977, presented in September 2005 with asymptomatic elevation of white blood cell and neutrophil count, and mildly-elevated C-reactive protein levels. He was a smoker since 1996 and was treated with 20 mg/day of simvastatin since 2003 due to hyperlipidemia. Clinical examination, and laboratory and imaging investigations ruled out any infectious, haematological, rheumatological, or endocrine conditions. He was followed-up regularly and was advised to stop smoking. He had 2 unsuccessful attempts to quit smoking; one was unassisted and the second was performed with the use of both varenicline and nicotine replacement therapy (patches). During the subsequent 6.5 years, his leukocyte and C-reactive protein levels were repeatedly elevated; the condition was consistent with chronic idiopathic neutrophilia. In February 2012, he started using electronic cigarettes and he managed to quit smoking within 10 days. After 6 months, laboratory examination showed normalized leukocyte count and C-reactive protein levels, confirmed immediately by a second laboratory and by repeated tests after 1 and 2 months. Conclusion Smoking cessation with the use of electronic cigarette led to reversal of chronic idiopathic neutrophilia. The daily use of electronic cigarette may help preserve the beneficial effects of smoking cessation.

Sign in / Sign up

Export Citation Format

Share Document